142 related articles for article (PubMed ID: 24261083)
1. Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.
Bi X; Jin Y; Gao X; Liu F; Gao D; Jiang Y; Liu H
Eur J Mass Spectrom (Chichester); 2013; 19(2):111-21. PubMed ID: 24261083
[TBL] [Abstract][Full Text] [Related]
2. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
[TBL] [Abstract][Full Text] [Related]
3. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
[TBL] [Abstract][Full Text] [Related]
5. A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines.
Xiang Y; Liu Y; Yang Y; Hu H; Hu P; Ren H; Zhang D
Oncol Rep; 2015 Sep; 34(3):1249-60. PubMed ID: 26151126
[TBL] [Abstract][Full Text] [Related]
6. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.
Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
Hepatol Int; 2016 May; 10(3):493-500. PubMed ID: 26797719
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.
Zhang QL; Tian DA; Xu XJ
Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.
Li C; Tan YX; Zhou H; Ding SJ; Li SJ; Ma DJ; Man XB; Hong Y; Zhang L; Li L; Xia QC; Wu JR; Wang HY; Zeng R
Proteomics; 2005 Mar; 5(4):1125-39. PubMed ID: 15759316
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H
Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759
[TBL] [Abstract][Full Text] [Related]
10. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.
Zhang J; Hao N; Liu W; Lu M; Sun L; Chen N; Wu M; Zhao X; Xing B; Sun W; He F
Br J Cancer; 2017 Nov; 117(11):1676-1684. PubMed ID: 29024941
[TBL] [Abstract][Full Text] [Related]
11. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma.
Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F
Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810
[TBL] [Abstract][Full Text] [Related]
12. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
13. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
14. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
15. miR-125/Pokemon auto-circuit contributes to the progression of hepatocellular carcinoma.
Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
Tumour Biol; 2016 Jan; 37(1):511-9. PubMed ID: 26227218
[TBL] [Abstract][Full Text] [Related]
16. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
17. Differential proteomic analysis of hepatocellular carcinoma.
Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
[TBL] [Abstract][Full Text] [Related]
19. Pokemon reduces Bcl-2 expression through NF-κ Bp65: A possible mechanism of hepatocellular carcinoma.
Zhao X; Ning Q; Sun X; Tian D
Asian Pac J Trop Med; 2011 Jun; 4(6):492-7. PubMed ID: 21771706
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of differently expressed proteins in human hepatocellular carcinoma cell lines HepG2 with transfecting hepatitis B virus X gene.
Li WH; Miao XH; Qi ZT; Ni W; Zhu SY; Fang F
Chin Med J (Engl); 2009 Jan; 122(1):15-23. PubMed ID: 19187611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]